Biogen Inc. (LON:0R1B)

London · Delayed Price · Currency is GBP · Price in USD

149.78

+0.95 (0.64%)

At close: Oct 24, 2025

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
United States Revenue	3.34B	3.24B	Log In	Log In	Log In	Upgrade
International Revenue	3.87B	3.98B	Log In	Log In	Log In	Upgrade
Revenue (Other)	2.66B	2.46B	Log In	Log In	Log In	Upgrade
Revenue (Total)	9.86B	9.68B	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Multiple Sclerosis Revenue	4.18B	4.35B	Log In	Log In	Log In	Upgrade
Rare Disease Revenue	2.14B	1.99B	Log In	Log In	Log In	Upgrade
Alzheimer's Disease Revenue	-	-	Log In	Log In	Log In	Upgrade
Biosimilars Revenue	760.60M	793.10M	Log In	Log In	Log In	Upgrade
Other Product Revenue	-	82.50M	Log In	Log In	Log In	Upgrade
Total Product Revenue	7.21B	7.21B	Log In	Log In	Log In	Upgrade
Revenue (Other)	2.66B	2.46B	Log In	Log In	Log In	Upgrade
Revenue (Total)	9.86B	9.68B	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.